WORLD'S LARGEST MARKET RESEARCH RESOURCE — 1,519,265 REPORTS

 
 
• SEARCH FOR A REPORT

Search Results

Search
Enter keywords, a title or a report id number below.
Advanced

• SELECT SITE CURRENCY

Select a currency for use throughout the site



Your Search for 'Proteomic and Genomic Analysis of Cardiovascular Disease' returned 17 results - Page 1 of 1

Sort by

Sorted by Rank Top-Bottom
  • Proteomics - Technologies, Markets and Companies

    Jain PharmaBiotech, May 2013 , Pages: 631
    of medicine in the post-genomic era - the first decade of the 21st century. Most commonly used technologies are 2D gel electrophoresis for protein separation and analysis of proteins by mass ...
  • Biomarkers - Technologies, Markets and Companies

    Jain PharmaBiotech, May 2013 , Pages: 920
    Peptides in body fluids and tissues as biomarkers of disease Analysis of peptides in bodily fluids Serum peptidome patterns SISCAPA method for quantitating proteins and peptides in plasma Comparison of ...
  • Personalized Medicine - Scientific and Commercial Aspects

    Jain PharmaBiotech, May 2013 , Pages: 854
    diagnosis Proteomic strategies for biomarker identification Proteomic technologies for detection of biomarkers in body fluids Protein patterns Layered Gene Scanning Comparison of proteomic and genomic ...
  • The Convergence of Biomarkers and Diagnostics: Therapy area analyses, key products and future trends

    Scripp Business Insights, Apr 2008 , Pages: 265
    acceptance of biomarkers Prospects for companion diagnostics Biomarkers patent survey Chapter 8 Appendix Research Methodology Proteomic Cancer Biomarkers Biomarkers of Cardiovascular Disease and Stroke ...
  • Therapeutic Drug Monitoring - Technologies, Markets, and Companies

    Jain PharmaBiotech, May 2013 , Pages: 169
    drug safety studies Genomic technologies for toxicology biomarkers Proteomic technologies for toxicology biomarkers Metabonomic technologies for toxicology biomarkers Integration of genomic and ...
  • Cytogenetics - Technologies, Markets and Companies

    Jain PharmaBiotech, May 2013 , Pages: 231
    expression array and direct molecular analysis without amplification. Analysis of single-cell gene expression promises a more precise understanding of human disease pathogenesis and has important diagnostic ...
  • Molecular Diagnostics - Technologies, Markets and Companies

    Jain PharmaBiotech, May 2013 , Pages: 1090
    Prostate cancer Early detection of prostate cancer recurrence by nanotechnology Gene expression analysis of prostate cancer Huntingtin Interacting Protein 1 Integrative genomic and proteomic profiling of ...
  • Cell Therapy - Technologies, Markets and Companies

    Jain PharmaBiotech, May 2013 , Pages: 1050
    cells Cloned cells for transplantation medicine Claims of cloning of hESCs Cytogenetics of embryonic stem cells Stem cell proteomics Comparative proteomic analysis of somatic cells, iPSCs and ESCs ...
  • Animal Biotechnology - Technologies, Markets and Companies

    Jain PharmaBiotech, May 2013 , Pages: 370
    Genomics of disease resistance Genome wide associations and milk production in cows Low cost genotyping for genetic improvement in dairy cattle SNPs and longevity in dairy cattle Share genomic data to ...
  • Biomarker Technology Platforms for Cancer Diagnoses and Therapies

    TriMark Publications, Sep 2011 , Pages: 343
    Design 2.6.6 Exploiting the Power of MS to Improve Assay Specificity 2.6.7 Creating and Maintaining a Multi-Disease Product Pipeline 2.6.8 Partnerships for Developing Proteomic Biomarkers 2.7 Epigenic ...
  • Outlook of China Genomics and Proteomics Market - Application in Molecular Biomarker, Diagnostics and Personalized Medicine

    JZMed Inc, Jan 2011 , Pages: 282
    , product development capabilities in biomarkers and diagnostics, and portfolio distributions of genomic, proteomic and diagnostic products. With detailed analysis of the current market size of the Chinese ...
  • Biomarkers - Global Strategic Business Report

    Global Industry Analysts, Inc, Aug 2011 , Pages: 1305
    Myoglobin 53 New Diagnostic Biomarkers for ACS on the Anvil 54 Genomic Biomarkers for Detecting Cardiovascular Diseases 54 Growing Demand for Stroke Biomarkers 55 Rising Incidence of the Disease - A Major ...
  • Pharmacogenomics for Clinical Use and in Drug Development

    TriMark Publications, Jun 2009 , Pages: 244
    Serotonin Re-uptake Inhibitors 111 4.3.4.3 Mirtazapine and Venlafaxine 111 4.3.4.4 Nefazodone, Moclobemide, Reboxetine and Trazodone 111 4.3.5 Pharmacogenomics of Cardiovascular Disease 112 4.3.5.1 Beta ...
  • Heart Development and Regeneration

    Elsevier Science and Technology, May 2010 , Pages: 1136
    Cardiovascular Development and Disease 2.3 MicroRNA Regulation of Cardiac Development and Disease 3.1 Genomic Analysis in the Developing and Diseased Heart 3.2 Exploring Congenital Cardiovascular ...
  • Molecular Diagnostics - Global Strategic Business Report

    Global Industry Analysts, Inc, Nov 2012 , Pages: 572
    screening testing, food pathogen testing, cardiovascular disease testing, tissue typing testing and oncology testing to name a few. Almost all of donated blood is currently screened using molecular methods ...
  • Proteomics: Promising Research, Potential Applications, And New Developments (Technical Insights)

    Frost & Sullivan, Oct 2001
    Disease 3. Genicon Sciences: Measuring Minute Protein Levels 4. With IBM: Genomics Knowledge Platform Allows Integration of Genomic; Proteomic Data 5. With Galapagos: Overexpression of Human Genes in ...
  • Biochips - Products, Applications, Technologies and End-Use Markets Growth Analysis, 2009-2015

    Axis Research Mind, Feb 2011 , Pages: 599
    Biochips - Products, Applications, Technologies and End-Use Markets Growth Analysis, 2009-2015 Global Market Watch: Global biochips market is forecasted to reach US$9.1 billion by 2015 with a CAGR of ...
Results: First - Prev - 1 - Next - Last